Pre-Meeting Workshops

Clinical Trials Training Course (2017)

Content from this 2017 pre-meeting workshop from the 20th Annual Meeting is being shared online by popular request from Society membership.

Workshop Materials

Pre-Approval Commercialization

The Pre-Approval Commercialization Workshop covers industry perspectives on CMC Challenges for cell and gene modified cell therapy products, updates from global regulatory bodies, manufacturing challenges in late phase development of gene therapy products, and discussions on the difficulties in commercializing AAV product candidates.

Post-Approval Commercialization

The Post-Approval Commercialization Workshop includes sessions on patient focused drug development; post-approval change management and overall impact on commercialization; and pricing, reimbursement, and payment models for gene therapies.

Gene Editing

The Gene Editing workshop provides an overview of current gene editing technologies and approaches, emerging uses and applications, with sessions highlighting junior investigators and clinical gene editing programs.

CAR T and Related Immune Effector Cell Therapies

The CAR T and Related Immune Effector Cell Therapies workshop features discussions of the current state of CAR T therapeutic approaches in light of recent FDA approvals with updates on clinical long term follow-up. This workshop is in partnership with the Foundation for the Accreditation of Cellular Therapy and includes sessions on gene editing and going beyond autologous CAR-T cells for cancer.

2019
ASGCT Policy Summit
November 4 – 6 | Washington D.C.
Close